|
-
andrepharma3
2025-3-14
-
103
0
|
|
-
andrepharma3
2025-3-14
-
116
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
114
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
125
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
93
0
|
|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
jhonmiller
2025-3-13
-
98
0
|
|
-
jhonmiller
2025-3-12
-
102
0
|
|
-
globaltrust
2025-3-12
-
97
0
|